| 注册
首页|期刊导航|中国医院用药评价与分析|莫西沙星与孟鲁司特钠联合治疗支原体肺炎及感染后咳嗽的疗效观察

莫西沙星与孟鲁司特钠联合治疗支原体肺炎及感染后咳嗽的疗效观察

张俭俭 庄伟

中国医院用药评价与分析2017,Vol.17Issue(2):207-208,211,3.
中国医院用药评价与分析2017,Vol.17Issue(2):207-208,211,3.DOI:10.14009/j.issn.1672-2124.2017.02.022

莫西沙星与孟鲁司特钠联合治疗支原体肺炎及感染后咳嗽的疗效观察

Observation on Efficacy of Moxifloxacin Combined with Montelukast Sodium in Treatment of Mycoplasma Pneumonia and Post Infection Cough

张俭俭 1庄伟2

作者信息

  • 1. 中国人民武装警察部队学院医院药剂科,河北廊坊 065000
  • 2. 南京炮兵学院廊坊校区门诊部,河北廊坊 065000
  • 折叠

摘要

Abstract

OBJECTIVE:To probe into the clinical efficacy of moxifloxacin combined with montelukast sodium in treatment of mycoplasma pneumonia and post infection cough .METHODS: 102 patients with mycoplasma pneumonia were selected to be divided into observation group and control group via the random number table , with 51 cases in each . The control group were treated with 0.4 g moxifloxacin injections , once a day , combined with 10 mg oral montelukast sodium , once a day .The control group were given 0.5 g azithromycin , once a day , combined with oral compound Liquorice tablets , three tablets for once , three times a day .The clinical efficacy of two groups were compared and observed.RESULTS:The total effective rate of observation group and control group were respectively 94.12%(48/51) and 74.50%(38/51 ) , and the observation group was higher than that of control group , with statistically significant difference (P<0.05).The clearance time of fever , cough, wheeze, length of stay in observation group were significantly lower than those of control group , with statistically significant difference ( P <0.05 ) .CONCLUSIONS: Moxifloxacin combined with montelukast sodium in treatment of mycoplasma pneumonia and post infection cough can significantly shorten the clearance time of fever and improve the cough symptoms with remarkable efficacy .

关键词

莫西沙星/孟鲁司特钠/支原体肺炎/感染后咳嗽

Key words

Moxifloxacin/Montelukast sodium/Mycoplasma pneumonia/Post infection cough

分类

医药卫生

引用本文复制引用

张俭俭,庄伟..莫西沙星与孟鲁司特钠联合治疗支原体肺炎及感染后咳嗽的疗效观察[J].中国医院用药评价与分析,2017,17(2):207-208,211,3.

中国医院用药评价与分析

OACSTPCD

1672-2124

访问量0
|
下载量0
段落导航相关论文